Auster Martin has filed 4 insider transactions across 1 company since January 2024.
Most recent transaction: a sale of 1405 shares of Ventyx Biosciences, Inc. ($VTYX) on April 02, 2024.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 2, 2024 | Ventyx Biosciences, Inc. | $VTYX | Auster Martin | CHIEF FINANCIAL OFFICER | S | Common Stock | 1405 | $5.40 | 24,303.0000 | 0 | 5.47% | 0.00% |
| March 28, 2024 | Ventyx Biosciences, Inc. | $VTYX | Auster Martin | CHIEF FINANCIAL OFFICER | M | Common Stock | 4531 | $0.00 | 25,708.0000 | 0 | 21.40% | 0.00% |
| March 28, 2024 | Ventyx Biosciences, Inc. | $VTYX | Auster Martin | CHIEF FINANCIAL OFFICER | M | Restricted Stock Units | 4531 | $0.00 | 13,594.0000 | 0 | 25.00% | 0.00% |
| Jan. 2, 2024 | Ventyx Biosciences, Inc. | $VTYX | Auster Martin | Chief Financial Officer | A | Stock Option (right to buy) | 125000 | $0.00 | 125,000.0000 | 0 | 9999.99% | 0.00% |